Variation in lung cancer survival rates between countries: Do differences in data reporting contribute?

Respiratory Medicine

Volumn 100, Issue 9, 2006, Pages 1642-1646

  Butler, Claire A ^a,b   Darragh, Karen M ^a,b   Currie, Graeme P ^c   Anderson, Wendy J A ^a,b  

^a NORTHERN HEALTH AND SOCIAL CARE TRUST   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

Lung cancer; Mortality; Survival

Indexed keywords

CANCER INCIDENCE; CANCER MORTALITY; CANCER SURVIVAL; CONTROLLED STUDY; DEMOGRAPHY; EUROPE; FEMALE; GEOGRAPHY; HISTOPATHOLOGY; HUMAN; INFORMATION PROCESSING; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PRIORITY JOURNAL; SHORT SURVEY; STATISTICAL ANALYSIS; SURVIVAL RATE; UNITED KINGDOM; UNITED STATES;

DATA COLLECTION; DATA INTERPRETATION, STATISTICAL; EUROPE; GREAT BRITAIN; HUMANS; LUNG NEOPLASMS; RESEARCH DESIGN; SURVIVAL RATE; UNITED STATES;

EID: 33746211642     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2005.12.006     Document Type: Short Survey

References (25)

1. Coleman M.P., Gatta G., Verdecchia A., Esteve J., Sant M., Storm H., et al. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol 14 Suppl 5 (2003) v128-v149
2. Cancerstats monograph: cancer research UK, 2004. p. 45-54.
3. Gregor A., Thomson C.S., Brewster D.H., Stroner P.L., Davidson J., Fergusson R.J., et al. Management and survival of patients with lung cancer in Scotland diagnosed in 1995: results of a national population based study. Thorax 56 (2001) 212-217
4. SEER. www.seer.gov., 2005.
5. Gregor A., and Macbeth F. Non-small cell lung cancer: are we out of step?. Clin Oncol (R Coll Radiol) 7 (1995) 2-3
6. Sikora K. Cancer survival in Britain. Brit Med J 319 (1999) 461-462
7. Watson R. Europe is a 'second class continent' for cancer research. Brit Med J 330 (2005) 746
8. Department of Health. http://www.doh.gov.uk/cancer. The NHS Cancer Plan. London, 2000.
9. Department of Health. Improving outcomes in lung cancer: the manual (1998), Department of Health, London
10. Berrino F. The EUROCARE study: strengths, limitations and perspectives of population-based, comparative survival studies. Ann Oncol 14 Suppl 5 (2003) v9-v13
11. National cancer plan report 2: epimemiology. Copenhagen, 2000.
12. Scottish Health Statistics. www.isdscotland.org/.
13. Fitzpatrick D., Gavin A., Middleton R., and Catney D. Cancer in Northern Ireland 1993-2001. A Comprehensive report (2004), Northern Ireland Cancer Registry. Queens University Belfast, Belfast
14. Capocacia R., Gatta G., Roazzi P., carrani E., Santaquilani M., Angelis R.D., et al. The EUROCARE-3 database: methodology of data collection, stanadardisation, quality control and statistical analysis. Ann Oncol 14 Suppl 5 (2003) v14-v27
15. EUROCARE-2. Special Issue. Eur J Cancer 34 14 (1998)
16. Billing J.S., and Wells F.C. Delays in the diagnosis and surgical treatment of lung cancer. Thorax 51 (1996) 903-906
17. Seel M., and Foroudi F. Waiting for radiation therapy: does it matter?. Australas Radiol 46 (2002) 275
18. Saving lives: our healthier nation (1999), Department of Health, London
19. O'Rourke N., and Edwards R. Lung cancer treatment waiting times and tumour growth. Clin Oncol (R Coll Radiol) 12 (2000) 141-144
20. Berrino F., Saut M., Verdecchia A., et al. Survival of cancer patients in Europe. The Eurocare study (1995), IARC Scientific Publications, Geneva
21. Humphrey E.W., Smart C.R., Winchester D.P., et al. National survey of the pattern of care for carcinoma of the lung. J Thoracic Cardiovasc Surg 100 (1990) 837-843
22. Saunders M.I., Dische S., Barrett A., Harvey A., Gibson D., and Parmar M. A randomised multicentre trial of CHART vs. conventional radiotherapy in non-small cell lung cancer. Lancet 350 (1997) 161-165
23. Gatta G. Toward a comparison of survival in American and European cancer patients. Cancer 89 (2000) 893-900
24. seer.cancer.gov. SEER cancer statistics review, 1975-2001. 2005. p. 26-8.
25. Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 38 (1982) 933-942